Načítá se...
Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
Evidence about the treatment of hospitalized type 2 diabetes patients with incretin‐based therapy has emerged in the past 15 years. Based on this evidence, dipeptidyl peptidase‐4 inhibitors should be considered for hospitalized patients with type 2 diabetes and an algorithm for this is proposed. In...
Uloženo v:
| Vydáno v: | J Diabetes Investig |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078129/ https://ncbi.nlm.nih.gov/pubmed/31529777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13130 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|